“…Methylene blue is an oxidant; and thus can result in hemolysis and, paradoxically, methemoglobinemia in patients with G6PD deficiency. So although it is considered as the first line therapy for drug induced/poisoning related MetHb, a lot of factors need to be considered before using like availability, G6PD status, dose, duration, side effects (rebound methemoglobenemia and hemolysis) [9,10]. Automated therapeutic red cell exchange which is a much safe, efficacious and promising treatment modality with huge potential can be used in such cases assuring prompt relief following a single or may be a 2 day sitting.…”